These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6129982)

  • 1. Opioid peptides inhibit intestinal transit in the rat by a central mechanism.
    Galligan JJ; Burks TF
    Eur J Pharmacol; 1982 Nov; 85(1):61-8. PubMed ID: 6129982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative analysis of the shaking behavior induced in rats by beta-endorphin and [D-Ala2, Met5]enkephalinamide.
    Cowan A; Tortella FC
    Life Sci; 1982 Jan; 30(2):171-6. PubMed ID: 6275233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motility effects of opioid peptides in dog intestine.
    Burks TF; Hirning LD; Galligan JJ; Davis TP
    Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
    Galligan JJ; Burks TF
    J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
    Galligan JJ; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Jun; 229(3):641-8. PubMed ID: 6327967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal effect and analgesia: evidence for different involvement of opioid receptor subtypes in periaqueductal gray matter.
    Parolaro D; Crema G; Sala M; Santagostino A; Giagnoni G; Gori E
    Eur J Pharmacol; 1986 Jan; 120(1):95-9. PubMed ID: 2868906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma norepinephrine, epinephrine and dopamine responses to intracerebral administration of a met-enkephalin analog, D-ala2-met-enkephalinamide, in rats.
    Van Loon GR; Appel NM
    Neuroendocrinology; 1981 Sep; 33(3):153-7. PubMed ID: 6270584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system action of peptides to influence gastrointestinal motor function.
    Taché Y; Garrick T; Raybould H
    Gastroenterology; 1990 Feb; 98(2):517-28. PubMed ID: 2104814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility.
    Camilleri M; Malagelada JR; Stanghellini V; Zinsmeister AR; Kao PC; Li CH
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G147-54. PubMed ID: 2942039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
    Manara L; Bianchi G; Ferretti P; Tavani A
    J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
    Kapusta DR; Jones SY; Kopp UC; Dibona GF
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1039-47. PubMed ID: 2703962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered bombesin affects gastric emptying and small and large bowel transit in the rat.
    Porreca F; Burks TF
    Gastroenterology; 1983 Aug; 85(2):313-7. PubMed ID: 6862156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of lordosis behavior of female rats by naloxone, beta-endorphin and its antiserum in the mesencephalic central gray: possible mediation via GnRH.
    Sirinathsinghji DJ
    Neuroendocrinology; 1984 Sep; 39(3):222-30. PubMed ID: 6209590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.